1. Home
  2. News
  3. Genetic Signatures Ltd.
  4. 3base Kit for Antimicrobial Resistance Shows High Detection
More Genetic Signatures Ltd. news
Genetic Signatures Ltd.ASX: GSS

3base Kit for Antimicrobial Resistance Shows High Detection

Sep 28, 2022 at 11:45 PM EDT · Issued by Genetic Signatures Ltd.

Filed with ASX · Sep 28, 2022 at 11:45 PM EDT · 2 pages · English

On 6ix: 6ix.com/news/3base-kit-for-antimicrobial-resistance-shows-high-detection

Watch Genetic Signatures' latest callGenetic Signatures (ASX:GSS) Q4 2026 Earnings Call · Replay · Aug 25↗

Genetic Signatures Ltd. on 6ix

Story so far

  • TGA registration of SARS-CoV-2 detection kitApr 14, 2020

Earlier from Genetic Signatures

  • Full Year Statutory AccountsAug 31, 2022
  • Clinical trial recruitment completed for US enteric kitJul 26, 2022
  • Public Health Wales Awards Enteric Testing Contract to GSSMar 29, 2022
  • S&P DJI Announces March 2022 Quarterly RebalanceMar 4, 2022
  • 3base SARS-CoV-2 kit registered by TGA for saliva samplesJan 9, 2022

Later from Genetic Signatures

  • Response to ASX QueryOct 3, 2022
  • Influenza B Detection Expected to Impact on Quarter SalesAug 24, 2023
  • FDA 510(k) for Gastrointestinal Parasite Kit SubmittedSep 3, 2023
  • 510(k) Filing in Preparation for US Commercial LaunchSep 3, 2023
  • Quarterly update and Appendix 4COct 29, 2023
All Genetic Signatures news releases↗

Follow Genetic Signatures into a list and get an email when it puts out news.

Follow Genetic Signatures
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer